Thursday, July 9, 2026

Patent directory · USPTO A61K / A61P

Patents matching “Transgenion—International Institute for Regenerative Translational Medicine GmbH”

4 pharma patents match "Transgenion—International Institute for Regenerative Translational Medicine GmbH" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 4
Index total 30,257
Page 1 / 1

Quick answer

This filtered view shows 4 pharmaceutical patents matching "Transgenion—International Institute for Regenerative Translational Medicine GmbH" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

4 results for “Transgenion—International Institute for Regenerative Translational Medicine GmbH” · 30,257 patents in full index Clear search

  1. US 11124835

    Methods of diagnosing chronic obstructive pulmonary disease (COPD) using novel molecular biomarkers

    Transgenion—International Institute for Regenerative Translational Medicine GmbH · Granted Sep 21, 2021 · Expires Sep 16, 2041

    granted
  2. US 10604806

    Methods of diagnosing chronic obstructive pulmonary disease (COPD) using novel molecular biomarkers

    Transgenion—International Institute for Regenerative Translational Medicine GmbH · Granted Mar 31, 2020 · Expires Mar 26, 2040

    granted
  3. US 10526656

    Methods of diagnosing chronic obstructive pulmonary disease (COPD) using novel molecular biomarkers

    Transgenion—International Institute for Regenerative Translational Medicine GmbH · Granted Jan 7, 2020 · Expires Jan 2, 2040

    granted
  4. US 10508307

    Methods of diagnosing chronic obstructive pulmonary disease (COPD) using novel molecular biomarkers

    Transgenion—International Institute for Regenerative Translational Medicine GmbH · Granted Dec 17, 2019 · Expires Dec 12, 2039

    granted